Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. ✅
Go to Publication ✅
BMC gastroenterology (BMC Gastroenterol ) Vol: 10 Issue Pages: 110 Pub: 2010 Sep 19 Epub: 2010 Sep 19 Authors Lyra A , Krogius-Kurikka L , Nikkilä J , Malinen E , Kajander K , Kurikka K , Korpela R , Palva A , |
|
|
Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. ✅
Go to Publication ✅
BMC gastroenterology (BMC Gastroenterol ) Vol: 10 Issue Pages: 110 Pub: 2010 Sep 19 Epub: 2010 Sep 19 Authors Lyra A , Krogius-Kurikka L , Nikkilä J , Malinen E , Kajander K , Kurikka K , Korpela R , Palva A , |
|
|
Strategies to promote abundance of <i>Akkermansia muciniphila</i>, an emerging probiotics in the gut, evidence from dietary intervention studies. ✅
Go to Publication ✅
Journal of functional foods (J Funct Foods ) Vol: 33 Issue Pages: 194-201 Pub: 2017 Jun Epub: 2017 Mar 29 Authors Zhou K , |
|
|
Bifidobacterium breve UCC2003 Exopolysaccharide Modulates the Early Life Microbiota by Acting as a Potential Dietary Substrate. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 12 Issue 4 Pages: Pub: 2020 Mar 29 Epub: 2020 Mar 29 Authors Püngel D , Treveil A , Dalby MJ , Caim S , Colquhoun IJ , Booth C , Ketskemety J , Korcsmaros T , van Sinderen D , Lawson MA , Hall LJ , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
